Skip to main content
Quest Diagnostics

Always Better When We’re Together: A Novel, Collaborative Multi-Stakeholder Coalition Enhances National Guidelines for Hereditary Cancer Testing and Detection

2023 National Society of Genetic Counselors (NSGC) Conference

NSGC 2023

Chicago, IL, October 17-21, 2023

Poster presentation: Always Better When We’re Together: A Novel, Collaborative Multi-Stakeholder Coalition Enhances National Guidelines for Hereditary Cancer Testing and Detection

Authors: Dalton EK, Pilarski R  Sferrazza L, Gryzbowski J, Miller AM, Cummings S, Conlan K, Postula K,Johnson R, Schlager L, Dubin R, Struve F

Specialty: Genetics, Oncology

Related content

On-Demand Webinar
Hereditary Cancer Care Starts in Primary Care
Publication
Targeted BRCA1/2 population screening among Ashkenazi Jewish individuals using a web-enabled medical model: An observational cohort study
On-Demand Webinar
Genetic Testing: When should you consider testing beyond BRCA?
Audio Podcast
Optimize Oncology Care with Clinical Pathways
Test FAQ
Hereditary Colorectal Cancer Panel
Test FAQ
Guideline based Hereditary Cancer Panel
Test FAQ
Hereditary Breast Cancer Panel

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA certified laboratories that provide HIPAA covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.